Last year I wrote about an osteosarcoma meeting that I attended. I attended the same meeting this year in January, called the FACTOR 2018 Conference. The conference objective is to “Collaborate with all interested parties on advancing treatments and improving outcomes for patients with osteosarcoma.”
This meeting involved researchers from around the US and one from London, but also breakout sessions for kids with osteosarcoma and sessions for those grieving. It started Thursday with a free second opinion clinic run by the University of Miami Comprehensive Cancer Center.
Logan Spector, PhD spoke about the BOOST registry he has started at the University of Minnesota for osteosarcoma cases. Subree Subramanian PhD, also from UMN talked of epigenetics and their inﬂuence on genetics of the RNA molecule. Osteosarcoma research at the University of Minnesota is very active, and supported in part by Rein in Sarcoma to a tune of over $140,000 this year.
If you are interested in going to next year’s FACTOR meeting, it is open to all who have any connection at all to osteosarcoma, just email me and I will get you the information. (It’s in Miami in January).
John Seymour MD